Topic:
Analytical Testing
Latest Headlines
Latest Headlines
After Warnex buy, Biotrial jumps into bioanalytics
Now that it has paid about $6.1 million for Warnex's bioanalytics business, France's Biotrial Research is launching an offering all its own.
Solvias buys quality control business
Swiss CRO Solvias has bought Confarma, a French quality control consultancy.
Recipharm bets on analytical development with expansion
Swedish CDMO Recipharm is banking on a growing demand for analytical drug development services, planning to reconstruct its Solna, Sweden, facility to house its data-based offerings.
Charles River pays $27M for majority of Chinese company
Charles River Laboratories has inked a $27 million deal for 75% of Chinese research model design company Vital River.
Small CROs band together to better compete
Six small CROs are pooling their resources and joining together, looking to capitalize on what they see as a hole in the market for contract research.
Covance taps big data outfit for diabetes R&D
Covance is joining forces with GNS Healthcare to use the company's big data know-how to create models for drug-development success.
CoreRx triples capacity with Florida plant
CoreRx has moved into its new 35,000-square-foot facility in Clearwater, FL, and the new lab will more than triple the CRO's daily capactiy, the company said.
Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement
Based on the findings published in Quintiles' annual "New Health Report," payers want to get the ball rolling sooner to get drugs approved faster.
Warnex catches break in dealing with financial woes
The Canadian CRO gets an extended deadline to repay its debt, while securing a last-minute credit line of $2 million Canadian.
Proteome Sciences pushes to grow beyond CRO niche
Despite that anticipated growth, an analyst firm thinks the 40-employee-company's relatively small size may make it harder to lure Big Pharma clients.
